Literature DB >> 16166608

New approaches to measurement and treatment research to improve cognition in schizophrenia.

Mark A Geyer1, Robert Heinssen.   

Abstract

An overview is provided of the set of articles included in this special issue of Schizophrenia Bulletin that were derived from the final meeting of the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) program. These essays summarize the presentations and discussions of the MATRICS New Approaches Conference that examined the future needs of the field for a coordinated research effort to improve the preclinical and clinical science required to optimize new cotreatments for the cognitive deficits in patients with schizophrenia. Specific priorities for a research agenda involving collaborations among academic, industrial, and governmental participants are addressed.

Entities:  

Mesh:

Year:  2005        PMID: 16166608     DOI: 10.1093/schbul/sbi057

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  7 in total

1.  New paradigms for treatment development.

Authors:  Ellen L Stover; Linda Brady; Stephen R Marder
Journal:  Schizophr Bull       Date:  2007-08-02       Impact factor: 9.306

2.  Progress on NIMH initiatives (memorial theme for Wayne Fenton, MD).

Authors:  Ellen Stover; Steve Marder; William Carpenter
Journal:  Schizophr Bull       Date:  2007-07-19       Impact factor: 9.306

Review 3.  The family of sensorimotor gating disorders: comorbidities or diagnostic overlaps?

Authors:  Mark A Geyer
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

Review 4.  Removing obstacles in neuroscience drug discovery: the future path for animal models.

Authors:  Athina Markou; Christian Chiamulera; Mark A Geyer; Mark Tricklebank; Thomas Steckler
Journal:  Neuropsychopharmacology       Date:  2008-10-01       Impact factor: 7.853

5.  Insight into neurocognitive dysfunction in schizophrenia.

Authors:  Alice Medalia; Julie Thysen
Journal:  Schizophr Bull       Date:  2008-01-16       Impact factor: 9.306

Review 6.  The evolution of drug development in schizophrenia: past issues and future opportunities.

Authors:  William T Carpenter; James I Koenig
Journal:  Neuropsychopharmacology       Date:  2007-11-28       Impact factor: 7.853

Review 7.  Are cross-species measures of sensorimotor gating useful for the discovery of procognitive cotreatments for schizophrenia?

Authors:  Mark A Geyer
Journal:  Dialogues Clin Neurosci       Date:  2006       Impact factor: 5.986

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.